Literature DB >> 17509934

Sensitivity and specificity of three ELISA-based assays for discriminating primary from secondary acute dengue virus infection.

Vanda Akico Ueda Fick de Souza1, Adriana Fumie Tateno, Renato Reis Oliveira, Renan B Domingues, Evaldo Stanislau Araújo, Gustavo W Kuster, Cláudio Sérgio Pannuti.   

Abstract

BACKGROUND: Discrimination between primary and secondary dengue virus infection traditionally has been performed using the hemagglutination inhibition (HI) test. However, this test has practical limitations and disadvantages.
OBJECTIVE: To evaluate the ability of three ELISA-based methods (IgG avidity test, IgM/IgG ratio and IgG titer) to discriminate primary from secondary dengue infection. STUDY
DESIGN: Serum samples from convalescent-phase patients with confirmed acute, primary (n=46) or secondary (n=33) dengue virus infection were tested using three ELISA-based methods. A ROC curve was employed to establish the cut-off points and to evaluate the ability of the three methods to distinguish between acute, primary and secondary dengue virus infection.
RESULTS: All three assays exhibited sensitivity and negative predictive values of 100% for defining secondary infection. The specificity and positive predictive values were respectively 97.8% and 93.7% for the IgG avidity test, 95.7% and 88.2% for the IgM/IgG ratio assays, and 97.8% and 93.7% for the IgG titer assay.
CONCLUSION: All three ELISA-based assays proved reliable tools for discriminating between acute, primary and secondary dengue virus infection when using serum samples from convalescent-phase patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509934     DOI: 10.1016/j.jcv.2007.04.005

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  16 in total

1.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Spatial Distribution of Epidemiological Cases of Dengue Fever in Suriname, 2001-2012.

Authors:  D Hamer; M Lichtveld
Journal:  West Indian Med J       Date:  2015-05-01       Impact factor: 0.171

3.  Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

4.  Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.

Authors:  Wen-Yang Tsai; Anna Durbin; Jih-Jin Tsai; Szu-Chia Hsieh; Stephen Whitehead; Wei-Kung Wang
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

5.  Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

6.  Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.

Authors:  Willem G van Panhuis; Robert V Gibbons; Timothy P Endy; Alan L Rothman; Anon Srikiatkhachorn; Ananda Nisalak; Donald S Burke; Derek A T Cummings
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

7.  Kinetics of non-structural protein 1, IgM and IgG antibodies in dengue type 1 primary infection.

Authors:  Dongmei Hu; Biao Di; Xixia Ding; Yadi Wang; Yue Chen; Yuxian Pan; Kun Wen; Ming Wang; Xiaoyan Che
Journal:  Virol J       Date:  2011-02-02       Impact factor: 4.099

8.  High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.

Authors:  Wen-Yang Tsai; Chih-Yun Lai; Yi-Chieh Wu; Hong-En Lin; Carolyn Edwards; Amonrat Jumnainsong; Srisakul Kliks; Scott Halstead; Juthathip Mongkolsapaya; Gavin R Screaton; Wei-Kung Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

9.  Antibodies against immature virions are not a discriminating factor for dengue disease severity.

Authors:  Izabela A Rodenhuis-Zybert; Júlia M da Silva Voorham; Silvia Torres; Denise van de Pol; Jolanda M Smit
Journal:  PLoS Negl Trop Dis       Date:  2015-03-11

10.  Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.

Authors:  Chih-Yun Lai; Katherine L Williams; Yi-Chieh Wu; Sarah Knight; Angel Balmaseda; Eva Harris; Wei-Kung Wang
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.